We defined the normal and innate (without functional B or T cells) inflammatory response to infection with mouse cytomegalovirus (MCMV) or herpes simplex virus (HSV). Intraperitoneal infection with MCMV or HSV induced an inflammatory infiltrate consisting largely of macrophages (M) in both normal
HCMV is a significant pathogen in immunocompromised patients with AIDS, bone marrow transplants, and solid organ transplants (reviewed in references 32 and 33). Lack of immune responsiveness in newborns likely contributes to the severity of congenital HCMV infection (11) . Insight into anti-CMV immunity has come from studies of immunologically intact mice and mice with selective T-cell subset depletions infected with MCMV (16, 17, 21) . However, T-cell function is likely compromised in patients in whom HCMV causes severe disease. Thus, responses which are independent of T and B lymphocytes (innate) likely play a preeminent role in controlling CMV infection in immunocompromised hosts.
Several types of innate responses are important for resistance to MCMV. NK cells play an important role independent of T or B cells (5, 8, 35, 45) . Neutralizing anticytokine antibodies and cytokine treatment have shown that IFN␣/␤, IFN␥, and TNF␣ are important for MCMV resistance in immunocompetent mice (10, 13, 21, 27) . M have also been implicated in MCMV pathogenesis. Mononuclear phagocytes (possibly M) mediate dissemination of MCMV during primary infection (39) . Intraperitoneal infection with MCMV elicits M with increased Fc receptor expression (29) , and M are prominent in central nervous system lesions induced by guinea pig CMV (7) . M are also present in HSV-induced lesions of stromal keratitis (24) , suggesting that M may be a common component of inflammatory responses to herpesvirus infection.
The M has also been implicated as a site of HCMV latency (22, 26, 40) . Thus, understanding the M response to infection may be important to evaluating latency.
Because M and innate responses are important for MCMV pathogenesis, we analyzed M activation and its relationship to IFN␥ and TNF␣ in herpesvirus-infected SCID and immunocompetent CB17 mice. Herpesvirus infection activated M via IFN␥ and TNF␣ in both SCID and CB17 mice. TNF␣ played a role in migration of monocytes into the inflammatory site. Depletion of these cytokines increased the virus titer in peripheral organs of SCID mice and increased MCMV-induced pathology, demonstrating a T-and B-lymphocyte-independent role for these cytokines in MCMV resistance.
MATERIALS AND METHODS
Abbreviations. ATCC, American Type Culture Collection; CMV, cytomegalovirus; CPE, cytopathic effect; DMEM, Dulbecco's modified Eagle's medium; DMSO, dimethyl sulfoxide; FACS, fluorescence-activated cell sorting; FCS, fetal calf serum; FITC, fluorescein isothiocyanate; HCMV, human cytomegalovirus; HBSS, Hanks' balanced salt solution; HEPES, N-2-hydroxyethylpiperazine-NЈ-2-ethanesulfonic acid; HIV, human immunodeficiency virus; HSV, herpes simplex virus serotype 1 strain KOS; ICAM-1, intracellular adhesion molecule-1; IFN, interferon; Ig, immunoglobulin; IL, interleukin; i.p., intraperitoneal; LD 50 , 50% lethal dose; MAb, monoclonal antibody; M, monocyte/macrophage; MCMV, murine cytomegalovirus Smith strain (38); MHC, major histocompatibility complex; MOI, multiplicity of infection; NK, natural killer; PBS, phosphate-buffered saline; PECs, peritoneal exudate cells; SCID, severe combined immunodeficiency; SEM, standard error of the mean; TNF, tumor necrosis factor.
Medium and M cell culture. Tissue culture medium contained 2 mM Lglutamine, 100 U of penicillin per ml, and 100 g of streptomycin per ml (Biofluids, Rockville, Md. Viruses and viral assays. MCMV (ATCC VR-194, lot 10) and HSV (the gift of P. Olivo) were maintained as tissue culture-passaged stocks. MCMV was grown and titered in BALB/3T12-3 fibroblasts (ATCC CCL 164), while HSV was grown and titered in Vero cells (ATCC CCL 81). Cells were infected (MOI ϭ 0.01), and flasks were held until CPE was complete. Cells and medium were spun at 1,500 ϫ g for 10 min. The resulting supernatant was spun at 13,600 ϫ g for 2 h, and the virus-containing pellet was harvested in DMEM5%. The resuspended pellet was sonicated three times for 15 s each in an ice bath with a Sonifier 250 (Branson, Danbury, Conn.) on setting 2. Virus was stored in single-use vials at Ϫ70ЊC. Control cell extracts were prepared from mock-infected cells. Inactivated virus was prepared by UV irradiation ( ϭ 245 nm) for two 10-min cycles with the source 6 cm from the virus stock (model ENF-260C; Spectroline Westbury, N.Y.). No viable virus was detected by plaque assay after UV irradiation. 3T12 and Vero cells were negative for mycoplasma by the Mycoplasma TC test kit (Gen-Probe, San Diego, Calif.).
Animals, animal infection, and tissue harvest. CB17 and CB17 background SCID mice (H-2 d ) 6 to 12 weeks old were housed in a biosafety level 2 facility at Washington University in accordance with all federal and university policies. Sentinel animals were assayed every 3 months and were negative for adventitious mouse pathogens as determined by serology. SCID mice (even SCID mice with measurable serum IgG) from our colony do not mount specific humoral responses to viral infection (14a). Mice (n ϭ 3) were infected i.p. with virus (or mock control) diluted in DMEM5%. Mice were killed 7 days after infection, and PECs were harvested by peritoneal lavage with 15 ml of HBSS1% per mouse. Peripheral organs (approximately 0.2 g of liver, half of the spleen, and one lobe of the submandibular salivary gland) were harvested, minced, suspended in 1 ml of DMEM10% (containing 10% DMSO), and frozen at Ϫ70ЊC prior to titration by plaque assay.
Plaque assay. After sonication with a Sonifier 250 (Branson) on setting 2 for 10 s, 200 l of serial 10-fold dilutions of organ homogenates or virus stocks were plated in duplicate on 80 to 90% confluent monolayers of 3T12 or Vero cells in six-well tissue culture clusters (Costar, Cambridge, Mass.). After 1 h at 37ЊC, monolayers were washed (for organ homogenates) with 2 ml of PBS-2% FCS per well and then overlaid with 3 ml of DMEM/0.5% agar. Cells were incubated for 6 days (37ЊC, 5% CO 2 ) with a 2-ml second overlay on day 3. On day 6, plates were overlaid with 2.5% neutral red in DMEM containing 0.5% Noble agar and developed for 12 h, and plaques were counted.
Anticytokine antibodies. MAbs TN319.12, H22, and L2-3D9 were the gift of R. Schreiber (Washington University School of Medicine). MAb 1C10.A10.1D11, specific for recombinant HIV gp120, was the gift of Genentech (San Francisco, Calif.). TN319.12 and H22 neutralize TNF␣ (37) and IFN␥ (34) , respectively, while L2-3D9 reacts with recombinant but not natural murine IL2 (37) . Both TN319.12 and H22 are effective in vivo at the doses we selected (3, 4) . Studies using recombinant TNF␤/lymphotoxin show that TN319.12 has no activity against TNF␤/lymphotoxin (36a). Injections of L2-3D9, 1C10.A10.1D11, or pyrogen-free normal saline (Abbott Laboratories, Chicago, Ill.) were used as controls. No difference between any of these controls was observed. MAbs were injected i.p. at 250 g per mouse in 200 l of pyrogen-free saline 6 h prior to MCMV infection. In some experiments, a second 250-g dose was given 3 days after infection. Since there was no difference between treatment with one versus two doses of anti-IFN␥ or anti-TNF␣, we pooled data from these two groups. Polyclonal sheep antibody to mouse IFN␣/␤ was the gift of I. Gresser and was diluted 1:2 in pyrogen-free saline; 200 l was injected on day Ϫ2, day 0, and day 2 of infection. Table 1 for monoclonal antibodies used for FACs staining. Antibody 25-9-17s was prepared as ascites in SCID mice and purified on protein A. Both 25-9-17S and 10-2.16 were biotinylated (43) and used at 10 g/ml. Antibody 10-2.16 was used as a nonspecific binding control. Staining patterns were identical for 25-9-17S (IA, the MHC class II molecule encoded by the IA locus) and 14-4-4s (IE, the MHC class II molecule encoded by the IE locus) in all samples tested. F4/80 staining was performed with a 50% (vol/vol) dilution of F4/80 supernatant. F4/80 was detected by using FITC-conjugated goat anti-rat IgG (heavy and light chains) (Caltag, San Francisco, Calif.) at 8.3 g/ml. Biotinylated MAbs were detected with phycoerythrin-conjugated streptavidin (Molecular Probes, Eugene, Oreg.) at 10 g/ml. PECs were fixed in RPMI10% with an equal volume of 2% paraformaldehyde in PBS for 15 min at room temperature. Fixation was stopped by adding excess RPMI10%. Cells were spun down at 250 ϫ g and resuspended at 5 ϫ 10 6 cells per ml in staining wash (PBS with 1% bovine serum albumin and 1% sodium azide). A total of 10 6 PECs per sample were spun down (16,000 ϫ g, 4 s) and incubated in primary antibody for 30 min on ice. Cells were washed and incubated with secondary antibody for 30 min on ice, washed, and stored in 1% paraformaldehyde in PBS at 4ЊC. Flow cytometry was performed within 12 h of harvest to minimize autofluorescence.
Background fluorescence decreased in M from virally infected mice compared with that in those from mock-infected animals. Flow cytometry was done on a FACScan (Becton Dickinson, San Jose, Calif.), and data were analyzed using Consort 30 software (Becton Dickinson). Single-color histograms for M class II expression were generated by using F4/80 expression and forward scatter to gate on M. The percentage of M-bearing MHC class II was determined by setting markers on unstained M from mock-infected mice to include 2% of the cells. These markers were applied to experimental groups, and the percentage of cells with staining above the background level was calculated.
Histopathology. Differential counts were performed in a blinded manner on PECs adhered to glass slides using a Cyto-2 machine (Shandon-Lipshaw, Pittsburgh, Pa.) and stained with Wright's stain (Sigma). Cell yield per mouse for each cell type was calculated by multiplying the total cell yield per mouse by the percentage of each cell type. Tissues were fixed in 10% phosphate-buffered Formalin, embedded in paraffin, and stained with hematoxylin and eosin. Sections were prepared from spleen and liver and scored in a blinded manner by both authors for the number of intranuclear inclusion-bearing cells in 10 random fields using a net micrometer (250 m 2 /field, 40ϫ power). In vitro infection of M. PECs from naive CB17 mice were plated in 24-or 96-well tissue culture dishes (Costar) in triplicate. M were allowed to adhere for 4 h at 37ЊC in 5% CO 2 before nonadherent cells were removed by vigorous washing. Cells were left untreated or treated 2 h prior to infection with recombinant mouse IFN␥ (specific activity, 9.8 ϫ 10 6 U/ml) (Genentech Inc.) at 1, 10, or 50 U/ml. M were infected with MCMV at an MOI of 0.5 for 1 h on ice. Following infection, wells were washed three times to remove unbound virus, and one group was immediately frozen at Ϫ70ЊC to ascertain the amount of virus present at time zero. M were incubated for 5 days at 37ЊC in 5% CO 2 to allow MCMV growth and then frozen. Virus titer was determined by plaque assay after sonication.
Statistical analysis of data. Titer data was analyzed by two statistical methods. A two-way analysis of variance was performed to determine if significant differences existed within an overall set of data (e.g., M growth in vitro). Pairwise comparisons were then performed between individual groups for peripheral organ titer in anticytokine-treated animals using the least-significant-difference method. Differences were considered to be significant at P Ͻ 0.05. Pairwise comparisons of inclusion body data were performed by the Wilcoxon test.
RESULTS
M infiltration and activation in response to herpesvirus infection. CB17 and CB17 SCID mice were infected i.p. with 10 4 to 10 6 PFU of tissue culture-derived MCMV or 10 6 PFU of HSV. Tissue culture-derived MCMV had an LD 50 of 2 to 3 PFU in SCID mice (27a). Mock-infected mice received virusfree cell extract. After 7 days, PECs were harvested by lavage, counted, and characterized (Fig. 1) . Increasing doses of MCMV resulted in progressively larger inflammatory infiltrates in both immunocompetent and SCID mice. M ac- counted for the majority of exudate cells (Fig. 1) , with the number of M per mouse increasing two-to fourfold with high doses of MCMV in both SCID and CB17 mice. Exudates from infected CB17 mice contained more total cells than those from infected SCID mice, which was independent of the increased number of lymphocytes in the CB17 exudates (compare total cells with total lymphocytes in Fig. 1 ). This suggests that functional T or B lymphocytes enhance antiviral inflammation. Lymphocytes in SCID mouse PECs likely represent NK cells. Neutrophils accounted for a small proportion of herpesvirusinduced cellular exudates. Cell surface characteristics of activated M. M from mock-infected SCID and CB17 mice were rounded in appearance after adherence for 4 h on glass coverslips. In contrast, M from MCMV-or HSV-infected SCID and CB17 mice were flattened with ruffled edges, indicating activation. Activated M from MCMV-or HSV-infected SCID and CB17 mice expressed increased MHC class II (Fig. 2) and decreased F4/80 (not shown), a M-specific cell surface marker (1). Although class II expression on activated M was higher in immunocompetent CB17 mice than in SCID mice, M from MCMV-and HSV-infected SCID mice expressed more class II than those from mock-infected mice. Flow cytometry results for class II expression in CB17 and SCID mice were confirmed by fluorescent microscopy (not shown) (3). M from virally infected SCID mice showed variable class II expression. The uniformly high class II expression in CB17 mice may thus reflect a role for T cells in enhancing M class II expression. In addition to increased expression of MHC class II, infection with MCMV (Fig. 3) and HSV (not shown) increased MHC class I and ICAM-1 expression. This was seen in SCID (Fig. 3 ) and immunocompetent CB17 (not shown) mice. M activation was in response to live virus and not contamination with endotoxin, since challenge of CB17 and SCID mice with UVinactivated MCMV and HSV did not induce MHC class II expression, decrease F4/80 expression, increase class I or ICAM-1 expression, or induce a significant inflammatory infiltrate (not shown).
Role of IFN␥ and TNF␣ in virus-induced M activation and inflammatory responses. Neutralizing MAbs specific for IFN␥ or TNF␣ were administered to age-and sex-matched SCID and immunocompetent CB17 mice, followed by i.p. infection with 10 4 or 10 2 PFU (SCID) or 10 5 PFU (CB17) of MCMV. Seven days after infection, PECs were harvested and counted, and M were analyzed for F4/80 and MHC class II expression (Fig. 4) . Anti-IFN␥ treatment dramatically decreased MHC class II expression on M from MCMV-infected (Fig. 5) . Since there was no decrease in cell viability, the decreased number of M from anti-TNF␣-treated mice may reflect inhibition of M infiltration rather than increased cell death due to viral infection. Infiltration of other cell types was not significantly altered by anti-TNF␣.
Role of IFN␥ and TNF␣ in resistance of SCID mice to MCMV infection. Since IFN␥ and TNF␣ are involved in control of MCMV infection in immunocompetent mice, we evaluated their role in MCMV-infected SCID mice. Anticytokine MAbs were administered i.p., followed 6 h later by challenge with 10 6 PFU of MCMV. Virus titer in the spleen, liver, and salivary gland was evaluated 7 days after infection (Fig. 6) . IFN␥ depletion increased MCMV titer in spleen and liver but not in salivary gland. TNF␣ depletion increased virus titer in spleen but had no effect on the titer in liver or salivary gland. For comparison, mice treated with anti-IFN␣/␤ showed increased virus titer in spleen and liver (10) . Anti-IFN␣/␤-treated animals were killed a day earlier than other mice because they appeared ill, so differences between IFN␣/␤-treated and other groups are likely underestimated.
Tissue sections from cytokine-depleted SCID mice infected with MCMV were evaluated in a blinded fashion to determine the number of MCMV inclusion-bearing cells. Cytokine depletion increased the number of inclusion-bearing cells in an organ-dependent manner. Spleens from SCID mice receiving MCMV had 39 Ϯ 15 inclusion-bearing cells per 2,500 m Role of M in CMV infection. M are prominent in CMVinduced inflammatory responses ( Fig. 1 ) (7), arguing that M play an important role in control or dissemination of infection. Recent studies suggest that mononuclear phagocytes (possibly M) play a role in MCMV dissemination (39) . Several studies have shown that monocytes and macrophages can be infected with and/or are permissive for MCMV and HCMV replication (12, 28, 30, 36, 42) . M permissiveness for HCMV replication is dependent on the differentiation (activation) state of the M (15, 18, 23) . In contrast to M cultured in vitro, M in vivo show limited HCMV gene expression (41) . This argues that M are poorly permissive for replication in vivo, a finding consistent with our studies in freshly harvested M. M may therefore play a role in control of acute infection by taking up infectious virus and protecting more permissive cells from being infected. Consistent with this argument, M from MCMVinfected mice are less permissive for MCMV infection in vitro than M from uninfected mice (25) . Since treatment of M in vitro with IFN␥ decreases permissiveness for MCMV replication, M activation could be one effector mechanism for IFN␥.
Our findings in herpesvirus-induced M activation are notably similar to findings in the Listeria system. Listeria monocytogenes infection in SCID mice leads to M activation manifested by increased MHC class II expression, which is dependent upon NK cells, IFN␥, TNF␣, and IL1 (2) (3) (4) 31) . The importance of both NK cells and M to CMV resistance suggested that responses of M to MCMV infection might parallel those seen in the Listeria model. Thus, it seems likely that intracellular bacterial pathogens and herpesviruses both trigger the same host mechanisms of inflammation.
In addition to the potential role of activated M in control of acute CMV infection, our findings may relate to CMV latency. Bone marrow precursors of the monocyte/macrophage lineage are a potential site of HCMV latency (22, 26, 40) , and gene expression within the M is dependent upon the differentiation/activation state of the M (41). An intriguing possibility is that M activation (perhaps involving IFN␥ and/or TNF␣), and the consequent inhibition of lytic infection, plays a role in the establishment of latency.
In addition to potential roles in viral clearance or latency, M may also play an indirect role in MCMV clearance in immunocompetent hosts as antigen-presenting cells regulating T-cell responses. We found increased M MHC class I (Fig. 3) and MHC class II (Fig. 2) expression during viral infection. It is likely that enhanced expression of antigen-presenting molecules increases M antigen presentation. Activation of M could also influence the efficiency or nature of the T-cell response via expression of T-cell costimulatory molecules or secretion of regulatory cytokines. Role of IFN␥ in resistance to herpesvirus infection and herpesvirus-induced M activation. We evaluated the role of IFN␥ in MCMV resistance and MCMV-induced M activation because IFN␥ is important for control of MCMV infection in immunocompetent animals (13, 21) and is a well-known regulator of M activation. M from SCID mice receiving anti-IFN␥ expressed significantly less MHC class II than did those from MCMV-infected mice (Fig. 4) . This reflects the importance of IFN␥ in MHC class II induction on M in vivo (3). Anti-IFN␥ did not completely eliminate MHC class II expression, raising the possibility that IFN␥-independent MHC class II expression occurs during herpesvirus infection. Since SCID mice lack functional T and B cells, NK cells are the probable source of IFN␥ in virus-infected SCID mice. Thus, our results suggest that IFN␥ production may be a key component of the NK cell-mediated response to MCMV. Consistent with this, IFN␥ depletion resulted in increased MCMV titers, comparable to those seen in NK cell-depleted SCID mice (45) . NK cell-derived IFN␥ may inhibit MCMV replication in vivo through direct inhibition of viral replication in multiple infected cell types, activation of M, or enhancement of NK cell cytotoxic activity (20, 44) .
Role of TNF␣ in herpesvirus-induced M activation and resistance to MCMV infection. Neutralization of TNF␣ increased the virus titer in spleen and altered the number and activation state of virus-induced inflammatory M. The role for TNF in control of virus titer could be explained by direct antiviral effects (20) or an indirect effect, such as synergy with IL12 in enhancing NK cell IFN␥ production (4, 9) . In contrast to the impressive effects of IFN␥ neutralization, neutralization of TNF␣ had only a partial effect on M MHC class II expression (Fig. 4) . While this could reflect incomplete neutralization of TNF␣, the dose of anti-TNF␣ that we used inhibits TNF␣-dependent MHC class II induction during infection with L. monocytogenes (4) . Alternatively, neutralization of TNF␣ might inhibit the influx of recently bone marrow-derived monocytes/M, with a consequent decrease in MHC class II expression, since recently bone marrow-derived M are more responsive to IFN␥ than resident M (6). In support of this hypothesis, neutralization of TNF␣ significantly decreased the number of M in virus-induced peritoneal exudates (Fig. 5) , and a similar phenomenon occurs in TNF␣-depleted SCID mice infected with L. monocytogenes (33a) . The finding that neutralization of TNF during rat CMV infection decreased cellular infiltration into the lung could be explained by a role for TNF␣ in recruitment of monocytes (14) .
MHC class II expression during herpesvirus infection. M are a major part of the cellular inflammatory response to both MCMV and HSV, and one component of this M activation is IFN␥-and TNF␣-dependent MHC class II induction. This contrasts with a previous report that infection with HSV strain KOS inhibits MHC class II expression in the brain (19) . This may reflect differences in Ms, infected cell types, or cytokines in brain versus peritoneum. An alternative possibility is that HSV strains differ in their capacity to induce class II expression. However, we have found that several strains of HSV type 1, including KOS (this report), MacRae, and strain 17, induce M activation and increase MHC class II expression (manuscript in preparation). In contrast to the results reported here for low doses of MCMV, we have found that 10 6 PFU of MCMV inhibits M expression of MHC class II in SCID mice (manuscript in preparation). This interesting property of MCMV (and possibly certain strains of HSV) may well be related to the pathogenesis of herpesvirus infection.
